Typical applications of K-PH-ML-D5-KV2 include vibratory feeding of cohesive API’s that usually would build up when fed through standard twin screw configurations. The K-PH-ML-D5-KV2 has an easy-to-clean design,
The Phase I study is expected to recruit 22-37 patients with advanced or metastatic solid tumors for which no effective therapy is currently available, or whose cancer has
Lilly‘s Liprotamase is currently under FDA review as a treatment for exocrine pancreatic insufficiency (EPI). In the committee had questions about the degree of efficacy of Liprotamase and
Laprolan distributes wound care, ostomy care and urology products into the Dutch market. As per the agreement, Laprola is expected to receive around EUR10.35m from Rochester Medical in
Under the terms of the agreement, DSL has exclusive rights to sell and distribute Oxygen Biotherapeutics’ Dermacyte skin care products that it purchases throughout the European Union, Switzerland
SRI researchers will support NHLBI’s Science Moving TowArds Research Translation and Therapy (SMARTT) Program to provide resources that assist translation to the clinic of novel therapeutics for the
Johnson & Johnson has been held accountable for not having notified consumers who bought the defective product, and exposed other consumers to potential danger from its use. The
Calcitonin is a drug indicated for the treatment of postmenopausal osteoporosis, hypercalcemia, and Paget’s disease, and is commercially available in subcutaneous, intramuscular and nasal routes. The open-label, single-dose,
In support of the collaboration, MMRF will provide funding of up to $1m for a Phase I trial evaluating ganetespib as a single agent and in combination with
Dance has been granted exclusive worldwide license to Aerogen’s aerosol technology for insulin delivery and the other terms of the agreement were not disclosed. Dance Pharma CEO John
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.